where in the stomach to inject semaglutide Subcutaneous Injection: What It Is and How Give One How & Where to Inject

stavudine and didanosine, and causes significant morbidity in 10-35% of patients [2,3]

To downregulate CYP8B1 expression level in liver, AAV-sh Cyp8b1 , which was provided by Prof

smaller, more frequent meals may reduce reflux Identify and avoid personal trigger foods (commonly citrus, tomatoes, chocolate, caffeine, alcohol, and fatty foods) Remain upright for at least 23 hours after eating Elevate the head of the bed by 1020 cm using blocks (not just pillows) Smoking cessation is strongly advised, as smoking exacerbates reflux Alternative acid suppression therapies: H2-receptor antagonists (such as famotidine) may be considered, though they are less potent than PPIs These can be taken in the evening, completely separated from morning Rybelsus dosing Alginate-containing antacids (e.g., Gaviscon) form a protective barrier and can be used as needed, taken at least 30 minutes after Rybelsus These are particularly useful for nocturnal symptoms Reviewing the need for ongoing PPI therapy: NICE guidance recommends regular review of PPI use , with consideration of step-down therapy or stopping treatment in appropriate patients Some patients may manage with on-demand PPI use rather than daily maintenance A trial period without PPI (under medical supervision) may reveal whether ongoing therapy is necessary Addressing GLP-1-related GI effects: Nausea and reflux-like symptoms from Rybelsus often improve after 48 weeks as tolerance develops Slower dose escalation may reduce GI side effects Taking Rybelsus with the smallest possible volume of water may help Alternative diabetes therapies: If GI side effects or medication timing proves unmanageable, discuss alternative options with your diabetes team Once-weekly subcutaneous semaglutide (Ozempic) or other GLP-1 receptor agonists avoid the absorption complexities of oral therapy Other oral diabetes medications with different mechanisms may be appropriate depending on individual circumstances Any changes to your acid reflux management or diabetes therapy should be made in consultation with your healthcare team, ensuring both conditions remain adequately controlled whilst minimising medication burden and interaction risks

References: KDIGO Clinical Practice Guideline for Acute Kidney Injury Goodman & Gilmans The Pharmacological Basis of Therapeutics Brenner & Rectors The Kidney British National Formulary (BNF) #Pharmacy #ClinicalPharmacy #NSAIDs #KidneyHealth #Hypertension #PatientSafety #MedicationSafety #EvidenceBasedMedicine #Pharmacology #Healthcare #RenalPharmacology #MedicalEducation To view or add a comment, sign in Expanding low-estrogen contraceptive options: The FDA has approved Gwyn Lo, a once-weekly transdermal patch delivering a low dose of estrogen for women of childbearing potential with a BMI under 30 kg/m2

For the past few years, scientists and doctors have been keeping a close eye on GLP-1s interaction with other hormones

Taking Too Many NSAIDs Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen can irritate the stomach lining and increase gastrointestinal risks when used alongside GLP-1s